Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant

作者
Meagan A. Jacoby,Eric J. Duncavage,Gue Su Chang,Christopher A. Miller,Jin Shao,Kevin Elliott,Joshua D. Robinson,Robert S. Fulton,Catrina C. Fronick,Michelle D. O’Laughlin,Sharon E. Heath,Iskra Pusic,John S. Welch,Daniel C. Link,John F. DiPersio,Peter Westervelt,Timothy J. Ley,Timothy A. Graubert,Matthew J. Walter
出处
期刊:JCI insight [American Society for Clinical Investigation]
卷期号:3 (5) 被引量:60
标识
DOI:10.1172/jci.insight.98962
摘要

Allogeneic hematopoietic cell transplantation (alloHCT) is a potentially curative treatment for myelodysplastic syndromes (MDS), but patients who relapse after transplant have poor outcomes. In order to understand the contribution of tumor clonal evolution to disease progression,we applied exome and error-corrected targeted sequencing coupled with copy number analysis to comprehensively define changes in the clonal architecture of MDS in response to therapy using 51 serially acquired tumor samples from 9 patients who progressed after an alloHCT. We show that small subclones before alloHCT can drive progression after alloHCT. Notably, at least one subclone expanded or emerged at progression in all patients. Newly acquired structural variants (SVs) were present in an emergent/expanding subclone in 8 of 9 patients at progression, implicating the acquisition of SVs as important late subclonal progression events. In addition, pretransplant therapy with azacitidine likely influenced the mutation spectrum and evolution of emergent subclones after alloHCT. Although subclone evolution is common, founding clone mutations are always present at progression and could be detected in the bone marrow as early as 30 and/or 100 days after alloHCT in 6 of 8 (75%) patients, often prior to clinical progression. In conclusion, MDS progression after alloHCT is characterized by subclonal expansion and evolution, which can be influenced by pretransplant therapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
2秒前
LG完成签到,获得积分10
2秒前
华仔的应助被小猪熊采纳,获得10
2秒前
霸气觅荷发布了新的文献求助10
2秒前
充电宝的应助被追寻采纳,获得10
2秒前
syr111发布了新的文献求助10
2秒前
小二郎的应助被薛妖怪采纳,获得10
3秒前
3秒前
3秒前
3秒前
强强仔仔完成签到 ,获得积分10
3秒前
3秒前
hua发布了新的文献求助10
4秒前
冷酷以山发布了新的文献求助10
4秒前
yqy完成签到,获得积分10
4秒前
lily发布了新的文献求助10
4秒前
hanliulaixi发布了新的文献求助10
4秒前
顺顺利利完成签到,获得积分10
4秒前
滴答滴发布了新的文献求助10
4秒前
4秒前
duwang完成签到,获得积分10
5秒前
沉默的晓旋完成签到,获得积分10
5秒前
hh完成签到,获得积分10
5秒前
6秒前
祁灵枫完成签到,获得积分10
6秒前
谨慎树叶发布了新的文献求助10
7秒前
西西完成签到,获得积分10
7秒前
8秒前
8秒前
8秒前
我是老大的应助被孙娴采纳,获得10
9秒前
c.hen发布了新的文献求助10
9秒前
9秒前
守护精灵发布了新的文献求助10
10秒前
西西发布了新的文献求助10
10秒前
三石完成签到,获得积分10
11秒前
沉淀发布了新的文献求助10
11秒前
CHUNQ完成签到,获得积分10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181072
求助须知:如何正确求助?哪些是违规求助? 9571092
关于积分的说明 21816478
捐赠科研通 7777477
什么是DOI,文献DOI怎么找? 3433418
关于科研通互助平台的介绍 2557638
邀请新用户注册赠送积分活动 2479460